Custom Lucite commemorating speaker participation in the 2016 Global Autism Innovation Roundtable, sponsored by UBS.
(6AKLA16)Custom Lucite commemorating speaker participation in the 2016 Global Autism Innovation Roundtable, sponsored by UBS.
(6AKLA16)Deal tombstone marking the sale by UDG Heathcare of its Irish drug wholesaler business to global pharmaceutical wholesaler McKesson. U.S.-based McKesson was represented in the transaction by Goldman Sachs.
(6LJWA83)Custom commemorative marking the global collaboration between Janssen Biotech and TESARO involving the treatment of prostate cancer, with a design incorporating a spinning heart.
(6ALR124)Deal tombstone marking the acquisition of Paris-based HRA Pharma. Goldman Sachs and private equity group Astorg were the purchasers.
(6LACA69)Lucite commemorative marking a research and development joint venture between Massachusetts-based CRISPR, and German drug company Bayer. The collaboration will center on CRISPR’s gene-editing technology, and focus on the treatment of conditions such as congenital heart disease, blood disorders, and blindness.
(6AGP903)Pill/tablet themed deal toy marking the sale by Bayer Korea of the drug Mercilon.
(6LACB53)Fitness-themed Lucite tombstone marking the acquisition of Cybex International, a manufacturer of commercial fitness equipment, including cardiovascular and strength products. Cybex is based in Medway, Massachusetts.
(6ADL583)Back view of pill-themed financial tombstone marking the purchase of New Zealand Pharmaceuticals (NZD). The acquirer was Australian private equity firm Archer Capital.
(6ALR257)